Article Text

PDF
Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target?
  1. R Anantharaman1,
  2. M Heatley1,
  3. C F M Weston2
  1. 1
    Department of Cardiology, Swansea NHS Trust, Swansea, UK
  2. 2
    School of Medicine, Swansea University, Swansea, UK
  1. Dr C F M Weston, Department of Cardiology, Swansea NHS Trust, Swansea SA2 8QA, UK; C.F.M.Weston{at}swansea.ac.uk

Abstract

Patients with acute coronary syndrome (ACS) often have raised blood glucose concentrations when admitted to hospital; a marker for poorer prognosis. Interventions to rapidly normalise blood glucose inconsistently are applied and with uncertain utility. Here we review the association of hyperglycaemia with outcome, present evidence that this hyperglycaemia reflects more than a pre-existing diabetic state and discuss mechanisms by which glucose may adversely affect the course of acute myocardial infarction (AMI). Finally, we seek evidence that intensive insulin treatment improves outcome.

Statistics from Altmetric.com

Footnotes

  • Funding: None.

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.